↓ Skip to main content

Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis

Overview of attention for article published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet
twitter
8 X users

Readers on

mendeley
53 Mendeley